<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02272621</url>
  </required_header>
  <id_info>
    <org_study_id>CMILE-bleeding</org_study_id>
    <nct_id>NCT02272621</nct_id>
  </id_info>
  <brief_title>Bleeding in Partial Upper Hemisternotomy Versus Full Sternotomy Aortic Valve Replacement</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single-center, open-label, randomized controlled trial. Patients scheduled for&#xD;
      aortic valve replacement (AVR) at Karolinska University Hospital in Stockholm, Sweden will be&#xD;
      eligible. One-hundred patients will be randomly assigned to either partial upper sternotomy&#xD;
      (50 patients) or full sternotomy AVR (50 patients). Inclusion criteria is severe aortic&#xD;
      stenosis referred for medically indicated isolated aortic valve replacement. Exclusion&#xD;
      criteria are inclusion in other trial, left ventricular ejection fraction less than 0.45,&#xD;
      previous cardiac surgery, or urgent/emergent surgery.&#xD;
&#xD;
      Mechanical and bioprosthetic (stented or sutureless) aortic valves will be implanted.&#xD;
      Clinical characteristics will be registered. Clinical postoperative outcomes including&#xD;
      bleeding outcomes will be registered. Routine blood sampling will be performed pre- and&#xD;
      postoperatively. All available data will be collected prospectively. Informed consent will be&#xD;
      obtained from patients meeting the inclusion criteria before the initiation of any&#xD;
      study-specific procedures.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2013</start_date>
  <completion_date type="Actual">October 2020</completion_date>
  <primary_completion_date type="Actual">October 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Universal definition of perioperative bleeding in adult cardiac surgery</measure>
    <time_frame>Within 3 days from surgery</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <condition>Heart Valve Diseases</condition>
  <arm_group>
    <arm_group_label>Partial upper hemisternotomy aortic valve replacement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Partial upper hemisternotomy AVR will be performed according to current standard of care practices.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Full sternotomy aortic valve replacement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Full sternotomy AVR through a standard median sternotomy will be performed according to current standard of care practices.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Minimally invasive aortic valve replacement</intervention_name>
    <arm_group_label>Partial upper hemisternotomy aortic valve replacement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Full sternotomy aortic valve replacement</intervention_name>
    <arm_group_label>Full sternotomy aortic valve replacement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ≥ 18 years of age&#xD;
&#xD;
          -  Severe aortic stenosis defined as aortic valve area of less than 1 cm2 or index area&#xD;
             of 0.6 cm2/m2 by echocardiography&#xD;
&#xD;
          -  Referred for medically indicated aortic valve replacement&#xD;
&#xD;
          -  Sinus rhythm&#xD;
&#xD;
          -  Provide written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inclusion in other trial&#xD;
&#xD;
          -  Left ventricular ejection fraction less than 0.45&#xD;
&#xD;
          -  Presence of any coexisting severe valvular disorder&#xD;
&#xD;
          -  Previous cardiac surgery&#xD;
&#xD;
          -  Urgent or emergent surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Cardiothoracic Surgery, Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>October 21, 2014</study_first_submitted>
  <study_first_submitted_qc>October 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2014</study_first_posted>
  <last_update_submitted>May 31, 2021</last_update_submitted>
  <last_update_submitted_qc>May 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska University Hospital</investigator_affiliation>
    <investigator_full_name>Magnus Dalén</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

